Everything you need to know about baby products, ingredients & information

pharmanewsdaily- November 14, 2018

Baby products or baby preparations are mainly used for babies to protect their skin and hair and they are made under hygienic conditions. Check out ... Read More

Calliditas Therapeutics initiates Phase 3 NEFIGARD trial for Nefecon to treat IgA nephropathy

pharmanewsdaily- November 14, 2018

Swedish pharmaceutical company Calliditas Therapeutics has initiated the Phase 3 NEFIGARD trial to evaluate its lead drug candidate, Nefecon, for treating IgA nephropathy (IgAN), commonly ... Read More

9 Health Benefits of Eggs – Know What Eating an Egg a Day Can Do For You

pharmanewsdaily- November 14, 2018

Find out the many health benefits of eggs and eating eggs daily. Are eggs good for weight loss, can eggs help in reducing blood pressure ... Read More

Distress reported in adults who face difficulty in controlling sexual feelings

pharmanewsdaily- November 12, 2018

As per the recent study’s findings, it is found that adults feel distressed when they feel difficult to control the sexual feelings. It is revealed ... Read More

Humacyte begins phase 2 Humacyl vascular trauma trial

pharmanewsdaily- November 10, 2018

Humacyl vascular trauma trial : Humacyte, a regenerative medical technology company, has started a phase 2 clinical trial of its investigational human acellular vessel (HAV) ... Read More

Ferring Pharmaceuticals launches Nocdurna in US to treat nocturia

pharmanewsdaily- November 10, 2018

Ferring Pharmaceuticals has announced the launch of Nocdurna (desmopressin acetate) in the United States, marking a significant advancement in the treatment of nocturia caused by ... Read More

Fresenius Kabi launches generic Arsenic Trioxide Injection in US to enhance oncology treatment options

pharmanewsdaily- November 4, 2018

German health care company Fresenius Kabi has announced the US launch of its new generic drug, Arsenic Trioxide Injection. This product, a generic version of ... Read More

Nordic Nanovector begins Phase 1b trial of Betalutin and Rituximab combo for follicular lymphoma

pharmanewsdaily- November 4, 2018

Nordic Nanovector has commenced the dosing of the first patient in its Phase 1b clinical trial, dubbed Archer-1, which aims to evaluate the combination of ... Read More

Pfizer’s Lorbrena receives FDA approval for advanced lung cancer treatment

pharmanewsdaily- November 3, 2018

Pfizer Inc., a leading US pharmaceutical company, has secured approval from the US Food and Drug Administration (FDA) for Lorbrena (lorlatinib), a groundbreaking treatment for ... Read More

Protecting Your Vein Health

pharmanewsdaily- November 2, 2018

Taking care of yourself and your body is a complex task, but there are a number of easy steps you can take to make sure ... Read More